clofibrate has been researched along with chloroform in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Babur, AA; Burdeniuk, VG; Geshelin, SA; Girlia, VI; Mishchenko, NV; Petrov, SR; Zimovskiĭ, VL | 1 |
Hennig, GE; Manautou, JE; Silva, VM; Whiteley, HE | 1 |
6 other study(ies) available for clofibrate and chloroform
Article | Year |
---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[The dissolution via the drain of "forgotten" calculi in the common bile duct after surgery].
Topics: Adult; Aged; Aged, 80 and over; Chloroform; Cholecystectomy; Clofibrate; Combined Modality Therapy; Drainage; Female; Gallstones; Humans; Male; Middle Aged; Postoperative Complications; Procaine | 1992 |
Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Blood Urea Nitrogen; Bromobenzenes; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chloroform; Clofibrate; Injections, Intraperitoneal; Kidney; L-Iditol 2-Dehydrogenase; Liver; Male; Mice; Mice, Inbred C57BL; Microbodies; Sulfhydryl Compounds | 1998 |